The second month of any quarter is considered very important because most of the listed companies will have completed their mandatory reporting of quarterly results. Vivekam carried out the analysis of its recommendations in the month of February as has been the practice for the past several months. However, to be fair in comparison, recommendations given in large cap stocks are compared with nifty for outperformance and that of MidCap stocks are compared with nifty MidCap 50.
There were 18 trading days in the month of February requiring 180 recommendations in large cap and 180 recommendations in MidCap at a rate of 10 stocks per day. To term any recommendation a success, the said recommendation must have appreciated more than the maximum seen by the respective index in the period beginning from the day of recommendation till the end of this month.
For instance, the difference between the peak price seen in the stock in the month of February and that of 3 February 2014, when the stock was recommended by Vivekam, should be more than the difference in respective index measured in the same manner. Only then the recommendation is considered as an out performer. In the large cap segment out of 180 recommendations 142 have performed better than nifty index recording a success percentage of 78.89%.
Stock recommended |
Days recommended |
Days out performed |
TCS |
18 |
16 |
JSW Steel |
18 |
15 |
Bharti Airtel |
18 |
5 |
Sesa Sterlite |
18 |
4 |
GAIL (India) |
17 |
13 |
Power Fin.Corpn. |
14 |
14 |
Aurobindo Pharma |
14 |
14 |
Bharti Infra. |
13 |
13 |
LIC Housing Fin. |
13 |
12 |
Axis Bank |
11 |
11 |
Sun Pharma.Inds. |
9 |
9 |
Motherson Sumi |
4 |
4 |
I D F C |
4 |
4 |
United Breweries |
4 |
4 |
P & G Hygiene |
4 |
3 |
Ipca Labs. |
1 |
1 |
For the entire month of February there were only 16 stocks from the large cap segment which could make to the top 10 recommended stocks from Vivekam. Some of them have remained outperformers on all days. Some companies managed to outperform on most days while a few stocks like Bharti airtel and Sesa Sterlite failed to outperform on most days.
Power Fin Corporation, Aurobindo Pharma, Bharti Infra, Axis Bank, Sun Pharma, Monterson Sumi, IDFC, IPCA Labs and United Breweries have outperformed the nifty on all the days they were recommended while TCS, LIC housing finance and JSW steel have outperformed on most occasions.
Vivekam provides an interface to spot MidCap stocks also on daily basis. In February 2014 Vivekam came out with 180 choices at a rate of 10 choices per day from mid-cap segment. Out of them 137 or 76.11% stocks have managed to perform better than nifty MidCap 50 index. The outperformance of large cap and MidCap over their respective indices demonstrates the power of scientific processes in selection of stocks worthy of investment.
There were 17 stocks altogether that managed to make it to the top 10 recommendations of Vivekam on any day during February 2014. As displayed in the table below some stocks have beaten nifty MidCap 50 index on all days under consideration while a few stocks have not been able to do so. The theme in the market for February 2014 was clearly in favour of large cap stocks owing to FDI infusion.
Stock recommended |
Days recommended |
Days out performed |
Dewan Housing |
18 |
18 |
EID Parry |
18 |
17 |
Kirl. Brothers |
18 |
13 |
Coromandel Inter |
18 |
9 |
Neyveli Lignite |
17 |
8 |
Essar Ports |
16 |
14 |
KRBL |
14 |
12 |
CEAT |
12 |
6 |
Hinduja Global |
12 |
4 |
Vinati Organics |
11 |
11 |
Tata Elxsi |
8 |
8 |
LIC Housing Fin. |
5 |
5 |
Finolex Inds. |
4 |
4 |
SPARC |
3 |
3 |
Eros Intl.Media |
3 |
3 |
UPL |
2 |
2 |
Carborundum Uni. |
1 |
0 |
Time and again Vivekam’s ability to spot the undervalued growth stocks is proven with evidence. Investors desirous of enriching their knowledge base and be able to invest wisely for better returns on their investments have been using Vivekam’s services. Feedback from investors to further improve the efficacy of the processes or the mode of delivery of undervalued growth stocks is welcome.